These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 10479411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis.
    Van Uden E, Kang DE, Koo EH, Masliah E.
    Microsc Res Tech; 2000 Aug 15; 50(4):268-72. PubMed ID: 10936878
    [Abstract] [Full Text] [Related]

  • 3. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E.
    Exp Neurol; 2001 Jul 15; 170(1):15-26. PubMed ID: 11421580
    [Abstract] [Full Text] [Related]

  • 4. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T, Ingelsson M, Fukumoto H, Ramasamy K, Kowa H, Frosch MP, Irizarry MC, Hyman BT.
    Brain Res; 2007 Aug 03; 1161():116-23. PubMed ID: 17586478
    [Abstract] [Full Text] [Related]

  • 5. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.
    Rebeck GW, Harr SD, Strickland DK, Hyman BT.
    Ann Neurol; 1995 Feb 03; 37(2):211-7. PubMed ID: 7531418
    [Abstract] [Full Text] [Related]

  • 6. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug 03; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 7. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
    Miettinen R, Riedel A, Kalesnykas G, Kettunen HP, Puoliväli J, Soininen H, Arendt T.
    J Chem Neuroanat; 2005 Oct 03; 30(2-3):105-18. PubMed ID: 16081247
    [Abstract] [Full Text] [Related]

  • 8. Decreased expression of both the low-density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression.
    de Vries TJ, Verheijen JH, de Bart AC, Weidle UH, Ruiter DJ, van Muijen GN.
    Cancer Res; 1996 Mar 15; 56(6):1432-9. PubMed ID: 8640836
    [Abstract] [Full Text] [Related]

  • 9. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.
    Terro F, Czech C, Esclaire F, Elyaman W, Yardin C, Baclet MC, Touchet N, Tremp G, Pradier L, Hugon J.
    J Neurosci Res; 2002 Aug 15; 69(4):530-9. PubMed ID: 12210846
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG.
    Acta Neuropathol; 2006 Oct 15; 112(4):405-15. PubMed ID: 16865397
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J, Erb C, Ebert U, Baumann KH, Popp A, König G, Klein J.
    Neuroscience; 2004 Oct 15; 125(4):1009-17. PubMed ID: 15120860
    [Abstract] [Full Text] [Related]

  • 15. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H, Sultana R, Keller JN, St Clair DK, Markesbery WR, Butterfield DA.
    J Neurochem; 2006 Mar 15; 96(5):1322-35. PubMed ID: 16478525
    [Abstract] [Full Text] [Related]

  • 16. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice.
    Eckert A, Schindowski K, Leutner S, Luckhaus C, Touchet N, Czech C, Müller WE.
    Neurobiol Dis; 2001 Apr 15; 8(2):331-42. PubMed ID: 11300728
    [Abstract] [Full Text] [Related]

  • 17. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1.
    Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, Borchelt DR.
    Neurobiol Aging; 2004 Aug 15; 25(7):885-92. PubMed ID: 15212842
    [Abstract] [Full Text] [Related]

  • 18. LRP in amyloid-beta production and metabolism.
    Bu G, Cam J, Zerbinatti C.
    Ann N Y Acad Sci; 2006 Nov 15; 1086():35-53. PubMed ID: 17185504
    [Abstract] [Full Text] [Related]

  • 19. Functional phenotype in transgenic mice expressing mutant human presenilin-1.
    Barrow PA, Empson RM, Gladwell SJ, Anderson CM, Killick R, Yu X, Jefferys JG, Duff K.
    Neurobiol Dis; 2000 Apr 15; 7(2):119-26. PubMed ID: 10783295
    [Abstract] [Full Text] [Related]

  • 20. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep 15; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.